CIGNA Government Services HomeDME MAC Jurisdiction C HomePart B Home

Send this page to a colleague

April 8, 2008

Corrections to Covered Indications for Docetaxel and Gemcitabine

(Note: There were covered indications incorrectly listed in the articles on Covered Indications for Chemotherapy Drugs and their Adjuncts)

Docetaxel (Taxotere) J9170 140.0 to 151.9, 158.9, 160.0 to 162.9, 174.0 to 175.9, 183.0-183.9, 185, 188.0-188.9, 195.0
Gemcitabine J9201 156.0-156.9, 157.0 to 158.9, 162.2-162.9, 164.2, 164.3, 164.8, 164.9, 174.0 to 175.9, 181, 183.0-183.9, 186.0-186.9, 188.0-188.9, 194.4, 200.00 to 202.98


An ISO 9001:2000 certified company

Home | About Us | Careers | Site Map | Disclaimer | Web Site Feedback | Contact Us


Centers for Medicare &  Medicaid Services